Mount Yale Investment Advisors, LLC Axsome Therapeutics, Inc. Transaction History
Mount Yale Investment Advisors, LLC
- $1.21 Billion
- Q2 2025
A detailed history of Mount Yale Investment Advisors, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Mount Yale Investment Advisors, LLC holds 2,366 shares of AXSM stock, worth $315,032. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,366Holding current value
$315,032% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
410Shares Held
37.4MCall Options Held
510KPut Options Held
541K-
Vanguard Group Inc Valley Forge, PA3.95MShares$525 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$439 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA1.69MShares$225 Million6.93% of portfolio
-
Rtw Investments, LP New York, NY1.52MShares$202 Million2.43% of portfolio
-
Macquarie Group LTD Australia, C31.14MShares$151 Million0.15% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.71B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...